20 ADHD Clinical Trials in Little Rock, AR (2026)

Q: Are there adhd clinical trials in Little Rock?

Yes, there are 20 adhd clinical trials currently recruiting in Little Rock, AR.

Q: How do I join a clinical trial in Little Rock?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you.

Q: Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting ADHD Studies in Little Rock

NCT06605404Recruiting

Pan-tumor MRD Study

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select s...

Little Rock, AR1,350 participantsParadigm Health

View Study Details

NCT06319820Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of ...

Little Rock, ARPHASE3641 participantsJanssen Research & Development, LLC

View Study Details

NCT05982561Recruiting

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer. This prospective, blinded study evaluates its efficacy in detecting recurrent...

Little Rock, AR500 participantsEarly is Good Inc.

View Study Details

NCT07717892Recruiting

A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD

This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to \<18 years...

Little Rock, ARPHASE3468 participantsAxsome Therapeutics, Inc.

View Study Details

NCT07717879Recruiting

A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD

This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in children aged 6 to \<12 years wit...

Little Rock, ARPHASE3468 participantsAxsome Therapeutics, Inc.

View Study Details

NCT06510374Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)...

Little Rock, ARPHASE3454 participantsFerring Pharmaceuticals

View Study Details

NCT04752722Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

This study will evaluate the safety and efficacy of intravesical administration of EG-70 in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phase...

Little Rock, ARPHASE1350 participantsenGene, Inc.

View Study Details

NCT06567743Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer....

Little Rock, ARPHASE2325 participantsCG Oncology, Inc.

View Study Details

NCT07755410Recruiting

A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

The purpose of this study is to measure safety and the improvement in symptoms in subjects with ADHD when taking ALKS 7290 tablets compared with placebo tablets....

Little Rock, ARPHASE2312 participantsAlkermes, Inc.

View Study Details

NCT04781140Recruiting

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD....

Little Rock, ARPHASE4286 participantsSupernus Pharmaceuticals, Inc.

View Study Details

NCT07480356Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naïve adults 18 years of age or older. The main questions it aims to ans...

Little Rock, ARPHASE3284 participantsProtara Therapeutics

View Study Details

NCT06545955Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3...

Little Rock, ARPHASE3250 participantsFerring Pharmaceuticals

View Study Details

NCT07475806Recruiting

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

People with a type of bladder cancer called muscle-invasive bladder cancer have cancer that has spread into the muscle wall of the bladder. The standard treatment is to have chemotherapy, followed by ...

Little Rock, ARPHASE2240 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT05685433Recruiting

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI)....

Little Rock, ARNA200 participantsValencia Technologies Corporation

View Study Details

NCT07309445Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer...

Little Rock, AR150 participantsJanssen Research & Development, LLC

View Study Details

NCT05951179Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

TARA-002-101-Ph2 is an open-label study to investigate the safety and anti-tumor activity of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1...

Little Rock, ARPHASE2131 participantsProtara Therapeutics

View Study Details

NCT06995677Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Phase 2 Study of TYRA-300 in FGFR3 Altered Low Grade, Intermediate Risk NMIBC...

Little Rock, ARPHASE290 participantsTyra Biosciences, Inc

View Study Details

NCT05710848Recruiting

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients wit...

Little Rock, ARPHASE175 participantsSURGE Therapeutics

View Study Details

NCT05932680Recruiting

Limited-duration Teclistamab

This is a single-arm, non-inferiority study in which patients who have achieved a very good partial response (VGPR) or better, according to International Myeloma Working Group (IMWG) response criteria...

Little Rock, ARPHASE275 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT05491525Recruiting

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC...

Little Rock, ARPHASE271 participantsUrovant Sciences GmbH

View Study Details

About ADHD Clinical Trials in Little Rock

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 20 adhd clinical trials recruiting participants in Little Rock, AR. These studies are seeking a combined 6,720 participants. Research is being sponsored by Paradigm Health, Janssen Research & Development, LLC, Early is Good Inc. and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Little Rock — FAQ

Are there adhd clinical trials in Little Rock?

Yes, there are 20 adhd clinical trials currently recruiting in Little Rock, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What adhd treatments are being tested?

The 20 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated October 12, 2026 from ClinicalTrials.gov